Equities

Biostem Technologies Inc

BSEM:PKC

Biostem Technologies Inc

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (USD)13.85
  • Today's Change0.36 / 2.67%
  • Shares traded51.37k
  • 1 Year change+361.67%
  • Beta1.4708
Data delayed at least 15 minutes, as of Nov 22 2024 20:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in USD

The one analyst offering a 12 month price target expects Biostem Technologies Inc share price to rise to 32.50 in the next year from the last price of 13.49.
High140.9%32.50
Med140.9%32.50
Low140.9%32.50

Earnings history & estimates in USD

On Nov 12, 2024, Biostem Technologies Inc reported 3rd quarter 2024 earnings of 0.32 per share.
Average growth rate+28.33%
Biostem Technologies Inc reported annual 2023 losses of -0.57 per share on Apr 01, 2024.
Average growth rate+8.06%
More ▼

Revenue history & estimates in USD

BioStem Technologies, Inc. had 3rd quarter 2024 revenues of 82.56m. This bettered the 78.22m estimate of the one analyst covering the company. This was 14,232.81% above the prior year's 3rd quarter results.
Average growth rate+143.20%
BioStem Technologies, Inc. had revenues for the full year 2023 of 16.68m. This was 142.62% above the prior year's results.
Average growth rate+142.62%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.